Artificial Intelligence in Drug Discovery: Challenges and Future Direction in Pharmaceutical Research
Year: 2025
Type: article
Abstract: Artificial Intelligence (AI) is transforming the pharmaceutical industry by accelerating drug discovery, improving prediction accuracy, and reducing development costs. Traditional methods of drug design are time-consuming, costly, and often limited by human interpretation. AI integrates computational modeling, big data analytics, and machine learning (ML) to revolutionize each phase of drug discovery from target identification to clinical testing. This review explores the mechanisms, technologies, and tools behind AI in drug discovery and evaluates its potential to enhance pharmaceutical research. Applications include target validation, de novo drug design, virtual screening, and toxicity prediction. Case studies such as Alpha Fold and Scientia demonstrate how AI reduces RCD timelines and enhances molecular precision. Challenges like data bias, interpretability, and regulatory gaps are also discussed. The review concludes that integrating AI with experimental pharmacology and omics data will establish a new paradigm of precision drug discovery.
Author: Dr. Sunil Jaybhaye*, Payal Kundkar, Nikita Pungle
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7115181384
